Analystreport

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) had its "neutral" rating re-affirmed by analysts at Piper Sandler. They now have a $37.00 price target on the stock.

Collegium Pharmaceutical, Inc.  (COLL) 
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.collegiumpharma.com